Cresset Asset Management’s US Physical Therapy USPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-4,314
Closed -$365K 2209
2024
Q3
$365K Buy
4,314
+72
+2% +$6.39K ﹤0.01% 1706
2024
Q2
$392K Sell
4,242
-22
-0.5% -$2.23K ﹤0.01% 1572
2024
Q1
$483K Buy
4,264
+28
+0.7% +$2.8K ﹤0.01% 1352
2023
Q4
$395K Buy
4,236
+114
+3% +$10K ﹤0.01% 1348
2023
Q3
$378K Buy
4,122
+706
+21% +$75.8K ﹤0.01% 1325
2023
Q2
$415K Buy
+3,416
New +$368K ﹤0.01% 1370
2021
Q4
Sell
-3,193
Closed -$354K 1305
2021
Q3
$354K Buy
3,193
+132
+4% +$15K ﹤0.01% 772
2021
Q2
$355K Buy
3,061
+952
+45% +$109K 0.01% 695
2021
Q1
$220K Buy
+2,109
New +$262K ﹤0.01% 822
2020
Q2
Sell
-2,896
Closed -$201K 743
2020
Q1
$201K Buy
2,896
+272
+10% +$28.7K 0.01% 510
2019
Q4
$300K Buy
2,624
+806
+44% +$100K 0.01% 429
2019
Q3
$237K Sell
1,818
-274
-13% -$35.7K 0.01% 448
2019
Q2
$256K Buy
2,092
+1,367
+189% +$157K 0.01% 371
2019
Q1
$76K Buy
725
+257
+55% +$27.6K ﹤0.01% 650
2018
Q4
$48K Buy
+468
New +$52K ﹤0.01% 490

Other funds holding USPH

Cresset Asset Management's USPH Position: Q4 2024 in Review

Cresset Asset Management sold out of US Physical Therapy (USPH) in Q4 2024, closing a stake of 4,314 shares — an estimated $365K sold.

Cresset Asset Management first reported a position in USPH in Q4 2018 and held it in 15 quarters. The position peaked at $483K in Q1 2024. 255 funds tracked by Wall St. Rank hold USPH as of Q4 2024.

  • Cresset Asset Management reported no remaining US Physical Therapy position as of Q4 2024 after selling out during the quarter.
  • Cresset Asset Management sold 4,314 US Physical Therapy shares in Q4 2024, an estimated $365K.
  • Cresset Asset Management first reported a position in US Physical Therapy in Q4 2018 and held it in 15 quarters.
  • Cresset Asset Management's US Physical Therapy position peaked at $483K in Q1 2024.
  • 255 funds tracked by Wall St. Rank held US Physical Therapy as of Q4 2024.

Based on Cresset Asset Management's 13F filing for Q4 2024, filed 14 Feb 2025.